Market Size, Growth & Valuation (2025-30)

Plasma Fractionation Market size was valued at around USD 31.18 billion in 2024 and is projected to reach USD 42.39 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 5.51% during the forecast period, i.e., 2025-30.

View Full Report - https://www.marknteladvisors.com/research-library/plasma-fractionation-market.html

Plasma Fractionation Market Structure – Segmentation & Geography

By Product

  • Immunoglobulin- Market Size & Forecast 2020-2030, (USD Million)
    • Intravenous Immunoglobulin- Market Size & Forecast 2020-2030, (USD Million)
    • Subcutaneous Immunoglobulin- Market Size & Forecast 2020-2030, (USD Million)
    • Other Disease Specific Immunoglobulins (Hepatitis B Immunoglobulin, Tetanus Immunoglobulin, etc.) - Market Size & Forecast 2020-2030, (USD Million)
  • Coagulation Factors- Market Size & Forecast 2020-2030, (USD Million)
    • Factor VIII- Market Size & Forecast 2020-2030, (USD Million)
    • Factor IX- Market Size & Forecast 2020-2030, (USD Million)
    • Von Willebrand Factor (vWF) - Market Size & Forecast 2020-2030, (USD Million)
    • Prothrombin Complex Concentrates- Market Size & Forecast 2020-2030, (USD Million)
    • Fibrinogen Concentrates- Market Size & Forecast 2020-2030, (USD Million)
    • Factor XIII- Market Size & Forecast 2020-2030, (USD Million)
    • Others (Factor VIIa, Factor XI, etc.)- Market Size & Forecast 2020-2030, (USD Million)
  • Albumin- Market Size & Forecast 2020-2030, (USD Million)
  • Protease Inhibitor- Market Size & Forecast 2020-2030, (USD Million)
  • Others (Plasminogen, Antithrombin III, etc.) - Market Size & Forecast 2020-2030, (USD Million)

The Immunoglobulin segment held a dominant influence on the Plasma Fractionation Market, contributing to the highest share of the overall revenue.

By Application

  • Neurology- Market Size & Forecast 2020-2030, (USD Million)
  • Immunology- Market Size & Forecast 2020-2030, (USD Million)
  • Hematology- Market Size & Forecast 2020-2030, (USD Million)
  • Critical Care- Market Size & Forecast 2020-2030, (USD Million)
  • Pulmonology- Market Size & Forecast 2020-2030, (USD Million)
  • Rheumatology- Market Size & Forecast 2020-2030, (USD Million)
  • Others (Oncology, Pediatrics, etc.) - Market Size & Forecast 2020-2030, (USD Million)

The Neurology segment held the major share of the Plasma Fractionation Market, owing to the rapid & effective response offered by Intravenous immunoglobulins (IVIG), compared to steroids and oral immunosuppressants.

By End User

  • Hospitals - Market Size & Forecast 2020-2030, (USD Million)
  • Specialty Clinics- Market Size & Forecast 2020-2030, (USD Million)
  • Research Facilities - Market Size & Forecast 2020-2030, (USD Million)

By Region

  • North America
  • South America
  • Europe
  • The Middle East & Africa
  • Asia-Pacific.

North America emerged as the dominant player in the Global Plasma Fractionation Market.

Key Growth Trends (2025-2030)

Add Trend.

Download Free Sample PDF - https://www.marknteladvisors.com/query/request-sample/plasma-fractionation-market.html

Research Methodology

MarkNtel Advisors employs a thorough and iterative research methodology to enhance accuracy in market estimates. Our process combines bottom-up and top-down approaches, focusing on data triangulation for validation. It includes defining research objectives, selecting representative samples, and collecting data through surveys and interviews. Post-collection, we analyze and validate the data using statistical tools, ensuring reliability. Finally, we forecast market trends through predictive modeling, compiling our insights into detailed reports with charts and strategic recommendations for informed decision-making.

Competitive Analysis Framework

The Plasma Fractionation industry is moderately fragmented, with key players focusing on technological advancements and strategic partnerships. A detailed competitive analysis helps businesses benchmark against industry leaders and identify growth opportunities.

Leading Plasma Fractionation Companies are:

  • Biotest A.G.
  • Octapharma A.G.
  • Adma Biologics
  • Aegros
  • CSL Limited
  • Grifols S.A.
  • Kedrion Biopharma Inc.
  • Bio Products Laboratory Ltd                                  
  • Takeda Pharmaceuticals
  • Emergent Bio solutions
  • Intas Pharmaceutical
  • Plasma Gen Biosciences
  • S K Plasma
  • Australian Red Cross Lifeblood
  •  

📊 Looking for a Customized Market Research Report? Visit – https://www.marknteladvisors.com/query/request-customization/plasma-fractionation-market.html

(Need global, regional or country-specific data? We can tailor research to your exact requirements)

Key Questions Answered in This Report:

  1. What is the current market size of Plasma Fractionation, and what growth rate is projected by 2030?
  2. Which key trends are driving Plasma Fractionation market expansion in the next five years?
  3. How does market segmentation impact industry dynamics?
  4. Which geographic regions offer the highest growth potential?
  5. What are the primary challenges hindering Plasma Fractionation industry growth?
  6. How do regulatory policies influence market development?
  7. What are the latest technological advancements impacting the sector?
  8. Who are the leading Plasma Fractionation companies, and what are their market shares?
  9. What strategies are top competitors adopting to maintain dominance?
  10. What are the emerging niche segments with high growth potential?
  11. How do macroeconomic factors affect market performance?
  12. What are the investment opportunities for new entrants?
  13. How does pricing strategy vary across different market segments?
  14. What are the future innovation trends expected in this industry?

Other Report:

About Us – MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, India, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact:

MarkNtel Advisors

Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India

Contact No: +91 8719999009

Email: [email protected]

Visit our Website: https://www.marknteladvisors.com